Topic

Articles

André Sode, CEO of Liva Healthcare, talks about Liva’s collaboration with Amgen to co-create an innovative digital tele-rehabilitation solution called Rehab+.

Amgen and Liva Healthcare Partner for Innovative Digital Tele-Rehabilitation Solution

The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.

Anticipating Digital Transformation of the Drug Development Workforce

Tahel Noy, Ph.D. and Bill Woywod, MPH, MBA are associate directors in the Life Sciences practice at 

Merging strengths of traditional behavioral and attitudinal research, capability enables pharmaceutical field teams to prioritize resources, targets, and outreach strategies.

Market Segmentation with Novel Machine Learning

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Recruitment of data scientists is much more than a numbers game.

Attracting the Right Data Science Talent

Christian Schuler is Senior Partner in the Life Sciences division of Simon-Kucher & Partners

Benedikt Porten is Consultant in the Life Sciences division of Simon-Kucher & Partners.

How can pharmaceutical companies successfully apply advanced analytics? Pricing experts from Simon-Kucher & Partners identify the hurdles and winning approaches.

Uncovering the Potential of Advanced Analytics in International Price Management

Remco Munnik is Associate Director at Iperion, a globally-operating life sciences consultancy firm which is paving the way to digital healthcare, and as such strongly committed to contributing to the actual implementation of the ISO IDMP standards. www.iperion.comRemco.munnik@iperion.com 

The European Medicines Agency (EMA) has published a guide to implementing IDMP data standards that will be ”a game changer” for the life sciences sector. Remco Munnik, who has been working with the EU focus group creating the EU IDMP Implementation Guide version 2, provides the inside track on the implications for life sciences companies.

EMA Launches Data Standards Implementation Guide: The Time to Act is Now

Pratap Khedkar, managing principal for ZS’ global pharmaceuticals practice, talks to Pharm Exec about what companies need to focus on to achieve and optimize digital transformation in 2021 and beyond.

The Path to Meaningful Digital Transformation

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

With the UK maintaining a world-leading position in key areas of technology, 2021 could be a banner year for its life sciences.

A ‘Golden Year’ for UK Life Sciences Sector?

Melissa Fellner of AstraZeneca and Leonie Goddard of Veeva, talk to Pharm Exec about how AZ’s mission to transform its digital strategies to better connect with customers.


Creating Connections: AstraZeneca's Digital Transition

Kal Patel, MD, is SVP of Digital Health, Flex.

Key takeaways on digital health from the 2021 JP Morgan Healthcare conference.

How to Build a Strategic Digital Health Function within Biopharma     

Laura Barrell, Senior Associate at VWV, outlines how the UK is emerging from the trials of Brexit and COVID to take a leading international role in the future of pharma and healthcare.

Optimism for the UK’s Life Sciences Future

Exploring the importance of analytics as a means of staying competitive in the commercial pharmaceutical market.

Competing in Commercial Pharmaceuticals: Get Formal and Familiar with Analytics

Sameer Lal and Sandeep Gantotti discuss the building of a next-gen medical information practice to modernize its operations and unlock its value to the wider organization and to HCPs.  

Moving MI Forward

Industry’s tardy shift to cloud-based solutions looks set to gather pace in 2021.

More Cloud on the Horizon for Pharma

Going beyond traditional market segmentation to understand the technological and data analytics capacity of target customers.

Bringing Data to Life: How Tech-Savvy Life Sciences Companies Can Better Serve the Healthcare Sector

The pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.

A ‘Sign’ of the Times: Digital Contract Transformation

To realize the promise of genomics, pharma must be prepared to mine the data more effectively.

The Emergence of Genomics 2.0: Advancing with Data

Janardan Prasad is CBO and Head of Life Sciences at Lore IO, providers of a pre-built, AI-powered common data model that enables unified data views and faster vendor onboarding. To learn more, visit the company at 

Owning a self-service data platform allows emerging pharma and biotech companies to accelerate past data engineering intricacies and focus on ad-hoc analytics to discern how their data can help them meet objectives for clinical operations, medical affairs, and commercial teams.

How A Self-Service Data Platform for Life Sciences Analytics Can Fast-Track Drug Readiness

Utilizing natural language processing technologies to improve search capabilities and advance the development of therapies.

Accelerating Rare Disease Drug Development with NLP: Three Use Cases

. He has more than 20 years of experience in management consulting and helps biopharmaceutical companies improve their data and analytical capabilities, as well as their brand commercialization and portfolio optimization strategies. Contact him at 

While patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.

Technology